Deal Experts for Korean Biopharma
The Biopharma industry in South Korea has grown significantly in the past decade. Having traditionally focused on generics and manufacturing, the industry has now transformed into an engine of innovation driven by the country’s cutting-edge science and technology.
Despite this achievement, however, many South Korean biopharma companies have struggled to reap the rewards of their hard work due to the challenges in accessing the global market. A popular solution to overcoming those challenges has been partnering & alliances with global biopharma.
How can we help you?
Over the past few years, PharmaVentures has successfully carried out over 40 BD&L projects with Korean clients. Leveraging over 30 years of experience in the global biopharma deal making scene, PharmaVentures has helped Korean companies to meet their strategic objectives by providing the following services:
In/out-licensing support for assets across different development stages
Valuation of assets/companies
Market research to support corporate strategy (e.g., asset development, indication prioritisation)
Fundraising
M&A
Pricing and Market Access
We also have 4 bilingual Korean speakers in our execution team with strong scientific/technical background, enabling PharmaVentures to provide differentiated services to Korean clients interested in exploring new business opportunities across the globe.
Dedicated Advisors
JungHyun Eom
Associate
Phone: +82 10 4388 9400
junghyun@pharmaventures.com
Jessie (Sangmin) You
Director
jessie@pharmaventures.com
Adrian Dawkes
Managing Director
Phone: +44 (0) 7931 428487
adrian@pharmaventures.com
12-14 July 2023
Bioplus Interphex Korea
JungHyun Eom is available for 1-1 meetings.
Previous Events
PharmaVentures is in partnership with several Korean government institutions to provide educational and thought leadership activities and is working towards globalising the Korean biopharma industry.
We have delivered numerous education series through various platforms to cover some of the basic concepts of deal making and share the best practice in negotiation and deal closure. Please find below different seminars and events that we have participated in the past:
10-12 May 2023
BIO Korea 2023
JungHyun Eom was available for 1-1 meetings.
11-13 May 2022
BIO Korea 2022
Dr Adrian Dawkes presented a talk on Device and Diagnostics Licensing. JungHyun Eom was available for 1-1 meetings.
7-8 October 2021
Seoul International Biomedical Conference
Dr Luke Lee, Associate, will be attending this event in person and will be available for 1-1 meetings.
11-13 October 2021
CPhI Korea
Dr Luke Lee, Associate, will be attending this event in person and will be available for 1-1 meetings.
21 October 2021
Seongnam International Medical Tourism Convention 2021
Dr Adrian Dawkes, Managing Director, will be presenting a session on the impact of COVID-19 on deal trends.
Our Case Studies
Watch On-Demand
SEOUL BIOHUB 2021
On the 24th June, Dr Adrian Dawkes, Managing Director, and Dr Luke Lee, Associate, took part in a valuation series at SEOUL BIOHUB to share insight into key valuation concepts and modelling approaches to support transactions with case study examples and live Q&A.
The valuation series includes:
• Seminar 1: Asset Valuation 101
• Seminar 2: Advanced Valuation Concepts
• Seminar 3: Real-World Application and Case Studies
• Q&A session
SEOUL BIOHUB 2020
On the 12th June 2020, Dr Adrian Dawkes, Managing Director, and Summer Park, Senior Business Development Director, took part in a number of live sessions at SEOUL BIOHUB 2020.